Empower Clinics Commences Corona Virus Covid-19 Antibody Testing and Establishes National Rollout Plan and Signs Supply Agreements for Rapid Covid-19 Test Kits

Shares :

0
(0)

Empower is utilizing clinic operations and tele-medicine to provide COVID-19 antibody testing to patients and consumers, establishes a four-phase nationwide rollout of Rapid COVID-19 testing and signs new COVID-19 test supply agreements.

VANCOUVER, BC / ACCESSWIRE / April 27, 2020 / EMPOWER CLINICS INC. (CSE:CBDT)(OTCQB:EPWCF)(Frankfurt:8EC) (“Empower” or the “Company”), a vertically integrated life sciences company is pleased to announce it has commenced COVID-19 antibody testing in its Sun Valley Health clinics in Phoenix, AZ using a blood draw test by clinic phlebotomists that are sent to an COVID-19 FDA approved laboratory partner. The laboratory submitted its request for FDA approval on March 16, 2020 under the Emergency Use Authorization (EUA).

“The Company has established a four-phase national COVID-19 testing program utilizing Rapid COVID-19 test kits”, said Steven McAuley, Chairman & CEO of Empower.

Phase One Testing in-clinics in Arizona, utilizing a patient blood draw by clinic phlebotomists, then samples are sent to our laboratory test partner for analysis, with test results expected within 48 hours.

Phase Two Offering a Rapid COVID-19 antibody test with results in 1-15 minutes. The service will be offered in-clinics using a drive-up service, conducted by Company clinic staff. In addition, an outbound door-step service, to support a variety of consumer, patient and community needs will be offered using certified mobile technicians. The Company anticipates phase two services will commence in May 2020.

Phase Three Business Employee Testing (BET) programs, offering Rapid COVID-19 testing to businesses on a one-time basis, repeat basis and/or subscription basis, to assist businesses to get back to work safely, will be offered. The Company anticipates phase three services will commence in May 2020.

Phase Four U.S. nationwide roll-out, offering all phases of Company services, that can be accessed online at Company websites and call centers, to purchase Rapid COVID-19 test kits. The Company anticipates phase four services to commence in Q3 2020.

Steven McAuley further states, “Our team are ready to meet the crisis head on, and we have ensured that the test processes and the test kits we use, are approved in the United States under the Emergency Use Authorization (EUA), as defined by the U.S. Food and Drug Administration (FDA).”

The Company has secured test kit supply agreements with two suppliers, NanoID Technologies Pty Ltd., that supply Zhuhai Livzon Diagnostics Inc. Rapid test kits, who made their test kit submission to the FDA on April 16th, 2020, and Emunah Trust, LLC, that supply Hangzhou TestSea Biotechnology Co., Ltd., Rapid test kits, who made their Rapid COVID-19 test kit submission to the FDA on April 16th, 2020.

CNN’s Dr. Sanjay Gupta explains what the science behind that testing means. Source: CNN

https://www.cnn.com/videos/health/2020/04/10/antibody-tests-fauci-week-or-so-gupta-dnt-lead-vpx.cnn

The World Health Organization, Director-General Dr. Tedros Adhanom Ghebreyesus has said, “Make no mistake: we have a long way to go. This virus will be with us for a long time. He has further stated, “We have a simple message for all counties: test, test, test.”

ABOUT EMPOWER

Empower is a vertically integrated health & wellness brand with a network of corporate and franchised health & wellness clinics in the U.S. The Company is building its first hemp-derived CBD extraction facility and produces its proprietary line of cannabidiol (CBD) based products. The company is a leading multi-state operator of a network of physician-staffed wellness clinics, focused on helping patients improve and protect their health, through innovative physician recommended treatment options. The Company has commenced activity on how to connect its significant data, to the potential of the efficacy of alternative treatment options related to hemp-derived cannabidiol (CBD) therapies, psilocybin and other psychedelic plant-based treatment options. The Company now offers COVID-19 testing options and physician- based consultations, to address COVID-19 concerns.


This image has an empty alt attribute; its file name is revivelogo2.2.png

REVIVE THERAPEUTICS | RVV HUGE NEWS

Revive Therapeutics Announces U.S. FDA Recommendation to Proceed Directly Into A Phase 3 Confirmatory Clinical Trial


If you like this article sign up below for our free newsletter

This article is written and published by The Cannabis Stock

Disclaimer : The Cannabis Stock wants to promote the cannabis market with the best articles and news on the market. The Cannabis Stock does not recommend selling or buying any of the company mentioned and is not responsible for any losses that may result. The Cannabis Stock are engaged in the business of marketing and advertising companiesReusable Block

The Cannabis Stock and its employees may from time to time own shares of the companies named in the articles. All the facts reported by the cannabis stock are information that comes directly from the companies, from their website or on Sedar and are only published as information.



Click on a star to rate this article !

Average rating 0 / 5. Vote count: 0

No votes so far! Be the first to rate this post.


Shares :